Versant Capital Management, Inc Celcuity Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 224 shares of CELC stock, worth $11,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224
Previous 349
35.82%
Holding current value
$11,213
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CELC
# of Institutions
100Shares Held
31.6MCall Options Held
40.2KPut Options Held
21.5K-
Baker Bros. Advisors LP New York, NY5.45MShares$273 Million0.74% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$174 Million1.82% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$151 Million3.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.29MShares$115 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$83.5 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $748M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...